+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Embolization Particle Market by Product Type (Gelatin Sponge Particles, Liquid Embolic Systems, Microspheres), Application (Hepatic Oncology, Neurovascular Procedures, Peripheral Arterial Embolization), End Use, Embolic Material, Mode of Action - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015269
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders seeking clarity in the embolization particle market will find a rapidly evolving sector at the intersection of technological innovation, clinical practice change, and regulatory adaptation. With diverse clinical applications and global supply shifts, understanding the landscape is essential for strategic planning and sustainable growth.

Market Snapshot: Embolization Particle Market Growth and Opportunities

The Embolization Particle Market grew from USD 1.79 billion in 2024 to USD 2.00 billion in 2025. It is expected to continue growing at a CAGR of 11.10%, reaching USD 3.37 billion by 2030. This robust expansion reflects growing demand for minimally invasive therapies in oncology, vascular disease, and women’s health, as well as increasing emphasis on targeted device innovation and tailored patient care. As awareness of embolization therapy rises and adoption broadens, both established and emerging manufacturers are recalibrating operations to address shifting regulatory and economic landscapes.

Scope & Segmentation

  • Product Types: Gelatin sponge particles, liquid embolic systems, microspheres, polyvinyl alcohol particles.
  • Clinical Applications: Hepatic oncology, neurovascular procedures, peripheral arterial embolization, prostate artery embolization, uterine fibroid embolization.
  • End Use Settings: Ambulatory surgical centers, hospitals, specialty clinics.
  • Embolic Materials: Collagen, gelatin, acrylic polymers, polyvinyl alcohol.
  • Mode of Action: Permanent and temporary occlusion agents.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including markets such as United Kingdom, Germany, France, Saudi Arabia, South Africa, and more); Asia-Pacific (including China, India, Japan, Australia, South Korea, and others).
  • Key Companies Analyzed: Boston Scientific Corporation, Terumo Corporation, Merit Medical Systems, Inc., Sirtex Medical Limited, Guerbet Group SA, AngioDynamics, Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Technological advancements are differentiating product offerings, resulting in enhanced procedural precision and more individualized patient outcomes across various clinical specialties.
  • Customizable embolic materials, including drug-eluting and bioactive platforms, are expanding therapeutic scopes and supporting the shift toward patient-centric, precision medicine approaches.
  • Value-based care models and evolving reimbursement criteria are reshaping investment strategies, with stakeholders seeking solutions that demonstrate both cost-effectiveness and measurable therapeutic outcomes.
  • Regional infrastructure maturity, from advanced interventional suites in North America to emerging facility networks in Asia-Pacific, is defining adoption speed and shaping patient access to care.
  • Collaborative research, strategic acquisitions, and cross-sector partnerships are accelerating clinical translation and supporting holistic product lifecycle management.
  • Active engagement with regulatory and clinical societies remains critical to streamlining approvals and navigating the complexities of evolving compliance requirements.

Tariff Impact: U.S. Policy and Global Supply Chain Shifts

Revised U.S. tariff schedules on embolization particle precursor chemicals and finished devices are altering global manufacturer cost structures, compelling industry stakeholders to re-examine sourcing models and distribution planning. Some producers are investing in localized manufacturing or switching to alternative suppliers in regions with favorable trade agreements. These adjustments create ripple effects across inventory logistics, partnership frameworks, and pricing strategies, emphasizing the importance of supply chain resilience in an increasingly complex regulatory landscape.

Methodology & Data Sources

This report uses a multistage research approach. Comprehensive secondary research established a foundation, followed by structured interviews with healthcare and regulatory experts. Triangulation of qualitative and quantitative data and validation by domain specialists ensured accuracy and actionable analysis at every stage.

Why This Report Matters: Actionable Value for Senior Stakeholders

  • Enables proactive risk management by offering clarity on regulatory shifts, supply chain vulnerabilities, and market entry barriers.
  • Supports pipeline prioritization and product development with segmentation intelligence that aligns with evolving end-user needs and reimbursement trends.
  • Equips leaders with a holistic framework to anticipate regional demand patterns and optimize resource allocation for sustained competitive advantage.

Conclusion

The embolization particle market is characterized by dynamic clinical and technological progress, set within a landscape of regulatory and economic transformation. Strategic agility and informed decision-making will be vital for continued leadership and successful market navigation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in use of drug-eluting microspheres for targeted embolotherapy in oncology and fibroid treatment
5.2. Development of biodegradable embolic particles to reduce long-term vessel occlusion risks
5.3. Rising adoption of radiopaque microspheres enabling real-time imaging during embolization procedures
5.4. Integration of image-guided robotic systems to enhance precision of embolic particle delivery in complex vessels
5.5. Shift towards personalized embolization strategies using particle size modulation based on patient anatomy and tumor vascularity
5.6. Emergence of combination embolic and immunotherapeutic particles to synergize tumor ablation with immune modulation
5.7. Growth in minimally invasive transarterial embolization using ultra-small spheres for neurovascular interventions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Embolization Particle Market, by Product Type
8.1. Introduction
8.2. Gelatin Sponge Particles
8.3. Liquid Embolic Systems
8.4. Microspheres
8.5. Polyvinyl Alcohol Particles
9. Embolization Particle Market, by Application
9.1. Introduction
9.2. Hepatic Oncology
9.3. Neurovascular Procedures
9.4. Peripheral Arterial Embolization
9.5. Prostate Artery Embolization
9.6. Uterine Fibroid Embolization
10. Embolization Particle Market, by End Use
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Embolization Particle Market, by Embolic Material
11.1. Introduction
11.2. Natural Materials
11.2.1. Collagen
11.2.2. Gelatin
11.3. Synthetic Materials
11.3.1. Acrylic Polymers
11.3.2. Polyvinyl Alcohol
12. Embolization Particle Market, by Mode Of Action
12.1. Introduction
12.2. Permanent
12.3. Temporary
13. Americas Embolization Particle Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Embolization Particle Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Embolization Particle Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Boston Scientific Corporation
16.3.2. Terumo Corporation
16.3.3. Merit Medical Systems, Inc.
16.3.4. Sirtex Medical Limited
16.3.5. Guerbet Group SA
16.3.6. AngioDynamics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EMBOLIZATION PARTICLE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EMBOLIZATION PARTICLE MARKET: RESEARCHAI
FIGURE 26. EMBOLIZATION PARTICLE MARKET: RESEARCHSTATISTICS
FIGURE 27. EMBOLIZATION PARTICLE MARKET: RESEARCHCONTACTS
FIGURE 28. EMBOLIZATION PARTICLE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EMBOLIZATION PARTICLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LIQUID EMBOLIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LIQUID EMBOLIC SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HEPATIC ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HEPATIC ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERMANENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERMANENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TEMPORARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TEMPORARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 100. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 101. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 102. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 103. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 104. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 105. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 106. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 107. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 108. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 118. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 119. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 188. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 190. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 191. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 192. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 202. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 204. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 205. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 206. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 208. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 223. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 228. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 229. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 230. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 231. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 232. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 233. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 234. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 235. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 236. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 244. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 246. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 247. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 248. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 250. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 293. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 300. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 302. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 303. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 304. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 305. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 306. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY NATURAL MATERIALS, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SYNTHETIC MATERIALS, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 321. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 326. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 327. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL, 2018-2024 (USD MILLION)
TABLE 328. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY EMBOLIC MATERIAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Embolization Particle market report include:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Sirtex Medical Limited
  • Guerbet Group SA
  • AngioDynamics, Inc.

Table Information